Los Angeles-based Evielab has launched and patented the industry’s first CBD/CBG solid sublingual pearl. Originally developed in France, Evie pearls measure just .15 inches and deliver 5 mg of the highest quality CBD and CBG.
LOS ANGELES, Feb. 26, 2020 /PRNewswire/ -- Los Angeles-based Evielab has launched and patented the industry’s first CBD/CBG solid sublingual pearl. Originally developed in France, Evie pearls measure just .15 inches and deliver 5 mg of the highest quality CBD and CBG. The innovative patent-pending micropearl technology dissolves quickly under the tongue and is as discreet as a breath mint. Each pearl consists of purified CBD and ultra-rare CBG (cannabigerol) combined with natural terpenes and come in effect-based profiles that may provide energy for sports performance, pain relief, relaxation, sexual drive, sleep, immunity and brain focus. Evie pearls are all natural with no additives, sugar, GMOs, or THC. “We’ve spent two years developing this process and the end product,” according to Xavier Suid, Founder of Evielab. “Evielab pearls are designed as a wellness product and we wanted users to have a very emotional connection to our product so it’s a high touch application, that is sexy and discreet enough to slip into your pocket.” High CBD Bioavailability for Faster Onset Dosing is in the User’s Control Patented Technology Evie pearls are available online at evielab.com. Any claims on this page have not been reviewed by the FDA. Media contact: View original content to download multimedia:http://www.prnewswire.com/news-releases/evielab-launches-first-solid-cbdcbg-sublingual-micropearls-301011091.html SOURCE Evielab |